Hyundai Bioscience Co Ltd 048410
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₩6,170.00
- Day Range
- ₩5,930.00–6,420.00
- 52-Week Range
- ₩4,565.00–21,500.00
- Bid/Ask
- ₩5,940.00 / ₩5,950.00
- Shares Outstanding
- 96.50M
- Market Cap
- ₩576.12B
- Volume/Avg
- 925,252 / 1M
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 167.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Hyundai Bioscience Co Ltd is a Korean biotechnology company. The company is engaged in developing and commercializing bio-fusion technology with the purpose of delivering active ingredients safely and efficiently to the body. It has developed Vitabrid CG, a biomaterial that binds vitamin C with bio-friendly mineral layers, which is a beneficial ingredient in skin brightening, anti-aging, and anti-inflammation; and Vitabrid C12, a premium skincare brand.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 69
Valuation
Metric | 048410 |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 5.68 |
Price/Sales | 167.89 |
Price/Cash Flow | — |
Price/Earnings
048410
Financial Strength
Metric | 048410 |
|---|---|
Quick Ratio | 2.30 |
Current Ratio | 2.36 |
Interest Coverage | −14.05 |
Quick Ratio
048410
Profitability
Metric | 048410 |
|---|---|
Return on Assets (Normalized) | −20.02% |
Return on Equity (Normalized) | −23.55% |
Return on Invested Capital (Normalized) | −20.06% |
Return on Assets
048410
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|@H^hh!l | LOCK|#<x#? | $136B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|%fZ%%d | LOCK|^th? | $99B | |||
| Moderna Inc MRNA | LOCK|!g>zS^ | LOCK|>bR | $87B | |||
| argenx SE ADR ARGX | LOCK|K<?>h%L | LOCK|Sn | $61B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|%&J&!X | LOCK|&w | $48B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|@r!&!QBj | LOCK|QHPsV | $31B | |||
| Incyte Corp INCY | LOCK|Z!wC!^ | LOCK|f< | $25B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|$TvcK@@ | LOCK|<?h?$ | $21B | |||
| BioNTech SE ADR BNTX | LOCK|Q$#$T#G | LOCK|@?M | $21B | |||
| Jazz Pharmaceuticals PLC JAZZ | LOCK|Xx^&$^j | LOCK|>s | $15B |